Mountain Valley MD Holdings Inc.
CA$0.07+CA$0.01 (+7.69%)
Mountain Valley MD Holdings Inc.’s quoted price sits in the upper half of its reported 52-week range, 33.33% below the high.
TSXV · THRM.V · CAD
Stock price, earnings
Quote as of Oct 28, 2026, 08:10 PM UTC. Cached market data; not a live quote.
One-year closing-price history · CAD. Historical prices are not a forecast.
Therma Bright Inc.’s quoted price sits in the lower half of its reported 52-week range, 72.73% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
BEHIND THE RESULTS
Upcoming dates and analyst estimates may change. Fiscal quarters follow Therma Bright Inc.’s reporting calendar.
THE COMPANY BEHIND THE TICKER
Established in Toronto, Canada, in 2001 as The Jenex Corporation before rebranding to Therma Bright Inc. in February 2018, Therma Bright Inc. specializes in creating and distributing various medical and consumer health products. Their diverse offerings include rapid COVID-19 diagnostic tests like AcuVid, which screens for both antigens and antibodies. For pain relief, they provide devices such as Benepod, a hot and cold contrast therapy system designed to manage discomfort without medication. The company also addresses circulatory issues with Venowave, a medical compression pump aimed at mitigating symptoms associated with poor circulation. Furthermore, Therma Bright caters to the cosmeceutical industry with products like InterceptCS, a cold sore prevention system utilizing safe, controlled topical heat, and TherOZap, a thermal device that alleviates the pain, itching, and inflammation from insect bites and stings by reducing the inflammatory response. Their clientele spans both individual consumers and healthcare practitioners.
Latest available per-share figures in CAD. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 11:07 AM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
CA$0.07+CA$0.01 (+7.69%)
Mountain Valley MD Holdings Inc.’s quoted price sits in the upper half of its reported 52-week range, 33.33% below the high.
CA$0.02-CA$0.01 (-25.0%)
Revive Therapeutics Ltd.’s quoted price sits in the lower half of its reported 52-week range, 81.25% below the high.
CA$0.05+CA$0.01 (+11.11%)
Avricore Health Inc.’s quoted price sits in the lower half of its reported 52-week range, 50.0% below the high.
CA$2.40CA$0.00 (0.0%)
Aptose Biosciences Inc.’s quoted price sits in the upper half of its reported 52-week range, 3.23% below the high.
CA$0.01CA$0.00 (0.0%)
1933 Industries Inc.’s quoted price sits in the lower half of its reported 52-week range, 50.0% below the high.
CA$0.05CA$0.00 (0.0%)
Telo Genomics Corp.’s quoted price sits in the lower half of its reported 52-week range, 52.38% below the high.
$0.03$0.00 (0.0%)
CordovaCann Corp.’s quoted price sits in the lower half of its reported 52-week range, 57.14% below the high.
CA$0.01CA$0.00 (0.0%)
TILT Holdings Inc.’s quoted price sits in the upper half of its reported 52-week range, 33.33% below the high.